Position in FONR
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$2,109,566
+$163,198 QoQ
Shares Held
113,662
+8.4% QoQ
Ownership
16.3%
of shares outstanding
% of Portfolio
1.75%
of 13F equity value
Holder Rank
#6
of 41 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 79.74169027467404.ToString("F0")%
Shared 0.ToString("F0")%
None 20.258309725325965.ToString("F0")%
Common Shares in FONR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Peapod Lane Capital LLC holds $5,617,535 across 2 Diagnostics & Research names. FONR ranks #2 (37.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FLGT |
Fulgent Genetics, Inc.
|
220,627 | $3,507,969 | |
| 2 | FONR |
Fonar Corp
This page
|
113,662 | $2,109,566 |
All Filings in FONR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,109,566 | 113,662 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,946,368 | 104,869 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,706,840 | 113,336 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,142,092 | 143,188 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,004,859 | 143,102 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,158,979 | 142,601 | Shares | Sole | 2025-01-29 | |
| No filing history on record for this holder in this stock. | ||||||